FDA Recalls 13K Bottles of Blood Pressure Medication Due to Dissolution Issues
The FDA has recalled over 13,500 bottles of chlorthalidone tablets due to failure to meet dissolution specifications. This Class II recall affects a medication used for high blood pressure and fluid retention, with concerns about potential health impacts.
Where it's breaking
Local coverage
Thyroid medication recall upgraded to FDA's highest risk level
FDA Upgrades Thyroid Medication Recall to Highest Risk Level
Thyroid medication recall elevated to FDA's highest risk level
Recall alert: 13K bottles of blood pressure medication recalled
FDA Recalls 13K Bottles of Blood Pressure Medication Due to Dissolution Issues
Thyroid medication recall classified under FDA's most urgent level
Thyroid medication recall upgraded to FDA's highest risk level
Thyroid medication recall upgraded to FDA's highest risk level
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.